SACRAMENTO, CA, February 24, 2012 (Press-News.org) Kershaw, Cutter & Ratinoff reports that the first of many hearings regarding the popular diabetes drug, Actos, has been scheduled to take place in Lafayette, Louisiana under U.S. District Judge Rebecca Doherty. The status conference will take place March 22, 2012, after which lead attorneys will be appointed for the consolidated cases.
According to an ongoing study involving more than 193,000 diabetes patients over the age of 40, those who took Actos to treat their diabetes for more than a year had a 40 percent higher risk of developing bladder cancer. Both France and Germany have halted sales of the drug since that news was published.
Kershaw, Cutter & Ratinoff filed suit* in November 2011 in Napa County Superior Court on behalf of a man who took Actos for a period of three years and subsequently was diagnosed with bladder cancer. The complaint alleges that Takeda knew about the link between Actos and bladder cancer, yet failed to warn patients. It is one of the Actos lawsuits being coordinated in the Louisiana Superior Court.
Thousands of other similar lawsuits are anticipated to be filed against Takeda Pharmaceuticals due to Actos' alleged associated risk for bladder cancer.
"This is another example of a dangerous drug that potentially creates an entirely new problem on top of the disease it treats," says Brooks Cutter, Kershaw, Cutter & Ratinoff partner and consumer protection advocate. "There are a number of other successful treatment options for diabetes. Quite simply, this drug should not be used."
The pharmaceutical lawyers at Kershaw, Cutter & Ratinoff encourage diabetes patients who have taken Actos for a year or more to contact a product liability attorney to discuss their rights. They note that many states restrict patients from pursuing legal action for certain time limits after discovering their medical product's potential for harm, so action should not be delayed.
For more information, send an email to Kershaw, Cutter & Ratinoff or visit their website at www.kcrlegal.com.
Kershaw, Cutter & Ratinoff represents plaintiffs in a wide range of personal injury lawsuits, pharmaceutical injury lawsuits and complex litigation. They have demonstrated their ability to devote substantial resources to lawsuits involving large corporations, generating hundreds of millions of dollars in recoveries for their clients and the classes they have represented.
*Rochester v. Takeda Pharmaceuticals America, Inc., et al., No. 26-57618 filed 11/15/2011 in Napa County Superior Court, California.
Actos Bladder Cancer Lawsuits to See First Hearing, Kershaw, Cutter & Ratinoff Reports
An initial court hearing date has been scheduled for the thousands of lawsuits against Takeda Pharmaceuticals over its best selling diabetes drug, Actos, which has been linked to an increased risk of bladder cancer.
2012-02-24
ELSE PRESS RELEASES FROM THIS DATE:
Brine Group Celebrates its 10-Year Anniversary
2012-02-24
Brine Group celebrates its 10 year anniversary as a successful recruiting firm providing outstanding placement services to its customers throughout the Metro Boston area and all the New England states.
*Our clients, with whom we have built critical business partnerships, have been a major component of this success.
*We are very proud of the many candidates that trusted us with their career searches along the way.
*At the pinnacle of our success are our employees who have worked so hard and committed themselves to servicing our customers and making Brine Group ...
More is better: Frequent or extended dialysis treatments benefit kidney failure patients
2012-02-24
Highlights
Frequent or extended dialysis treatments during the day or at night may improve patients' survival compared with conventional dialysis.
Nighttime or daily dialysis may also improve patients' health and reduce their need for medications.
Approximately 2 million patients in the world receive some sort of dialysis treatment.
Washington, DC -- Frequent and longer dialysis treatments may provide more benefits for patients than conventional dialysis treatments, according to several studies appearing in upcoming issues of the Journal of the American Society ...
Chicago's House of Blues Goes Green
2012-02-24
Last Thursday, February 16, 2012, The House of Blues in Chicago, IL featured hometown hip hop artist Nick Carter Green. The nearly sold out crowd rocked to the rhythms of jazz, funk, and rap as Green was backed by legendary percussionist Kahil El'Zabar. El'Zabar, also a Chicago native who has worked with Stevie Wonder, Nina Simone, Dizzy Gillespie and Paul Simon, called the show "a conversion of generations to celebrate the power of soul through hip hop."
Opening with his remix to Drake's "Headlines", which went viral on World Star Hip Hop back in ...
Genetic variants affect arsenic metabolism and toxicity in Bangladesh
2012-02-24
A large-scale genomic study conducted in Bangladesh has discovered genetic variants that control arsenic metabolism and elevate the risk of skin lesions in people chronically exposed to arsenic. In PLoS Genetics, researchers from the University of Chicago, Columbia University, the International Center for Diarrheal Disease Research in Bangladesh, and the University of North Carolina report that genetic variants found near the enzyme for metabolizing the chemical into a less toxic form are associated with an individual's risk of developing arsenic-related disease.
Since ...
For fish, fear smells like sugar
2012-02-24
When one fish gets injured, the rest of the school takes off in fear, tipped off by a mysterious substance known as "Schreckstoff" (meaning "scary stuff" in German). Now, researchers reporting online on February 23 in the Cell Press journal Current Biology have figured out what that scary stuff is really made of.
Within that chemical brew is a special type of sugar found in abundance in fish skin. When a fish is wounded, fragments of the sugar known as chondroitin sulfate alarm other fish nearby.
"Our results provide a solution to a 70-year-old puzzle: the nature of ...
Disarming the botulinum neurotoxin
2012-02-24
LA JOLLA, Calif., February 23, 2012 – Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) and the Medical School of Hannover in Germany recently discovered how the botulinum neurotoxin, a potential bioterrorism agent, survives the hostile environment in the stomach on its journey through the human body. Their study, published February 24 in Science, reveals the first 3D structure of a neurotoxin together with its bodyguard, a protein made simultaneously in the same bacterium. The bodyguard keeps the toxin safe through the gut, then lets go as the ...
Plastic Surgeon Comments on Tummy Tuck Advancements
2012-02-24
It's 2012, which for the plastic surgery industry means more advancements than ever before.
While groundbreaking technology and the emergence of new surgical techniques are exciting, potential patients should be sure that these innovations are time-tested before seriously considering them. A tummy tuck surgeon in Birmingham, Dr. Michael Beckenstein, stresses that patients should choose a surgeon based on the doctor's qualifications and experience with a particular procedure, and not just because he or she offers the "latest and greatest" treatments.
"As ...
Study: Evolution of earliest horses driven by climate change
2012-02-24
When Sifrhippus, the earliest known horse, first appeared in the forests of North America more than 50 million years ago, it would not have been mistaken for a Clydesdale. It weighed in at around 12 pounds -- and it was destined to get much smaller over the ensuing millennia.
Sifrhippus lived during the Paleocene-Eocene Thermal Maximum, a 175,000-year interval of time some 56 million years ago in which average global temperatures rose by about 10 degrees Fahrenheit, caused by the release of vast amounts of carbon into the atmosphere and oceans.
About a third of mammal ...
Genetic risk for elevated arsenic toxicity discovered
2012-02-24
One of the first large-scale genomic studies conducted in a developing country has discovered genetic variants that elevate the risk for skin lesions in people chronically exposed to arsenic. Genetic changes found near the enzyme for metabolizing the chemical into a less toxic form can significantly increase an individual's risk for developing arsenic-related disease.
The discovery could point the way to new screening and intervention options for people who are exposed to groundwater with high levels of arsenic, said scientists at the University of Chicago Medicine, Columbia ...
Italian vineyards invaded from North America by new species of leafminer
2012-02-24
Since in 2006 an unknown leafmining moth was found in North Italian vineyards by Mario Baldessari and colleagues, often in great numbers, scientists have tried to put a name to this apparently new invader. Italian scientists from the Fondazione Edmund Mach di San Michele all'Adige and the Università di Padova turned for help to taxonomists in the Netherlands and United States. The new species was described in the open access journal ZooKeys.
The family to which the moth belongs, the shield bearing leafminers (Heliozelidae) appeared to be poorly studied in North America, ...
LAST 30 PRESS RELEASES:
Mount Sinai Health system receives $8.5 million NIH grant renewal to advance research on long-term outcomes in children with congenital heart disease
Researchers develop treatment for advanced prostate cancer that could eliminate severe side effects
Keck Medicine of USC names Christian Pass chief financial officer
Inflatable fabric robotic arm picks apples
MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
Oil residues can travel over 5,000 miles on ocean debris, study finds
Korea University researchers discover that cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer
Ushikuvirus: A newly discovered giant virus may offer clues to the origin of life
Boosting the cell’s own cleanup
Movement matters: Light activity led to better survival in diabetes, heart, kidney disease
Method developed to identify best treatment combinations for glioblastoma based on unique cellular targets
Self-guided behavioral app helps children with epilepsy sleep earlier
Higher consumption of food preservatives is associated with an increased risk of type 2 diabetes
NTU Singapore-led team captures first-ever ‘twitch’ of the eye’s night-vision cells as they detect light, paving the way for earlier detection of blindness-causing diseases
Global aviation emissions could be halved through maximising efficiency gains, new study shows
Fewer layovers, better-connected airports, more firm growth
Exposure to natural light improves metabolic health
As we age, immune cells protect the spinal cord
New expert guidance urges caution before surgery for patients with treatment-resistant constipation
Solar hydrogen can now be produced efficiently without the scarce metal platinum
Sleeping in on weekends may help boost teens’ mental health
Study: Teens use cellphones for an hour a day at school
After more than two years of war, Palestinian children are hungry, denied education and “like the living dead”
The untold story of life with Prader-Willi syndrome - according to the siblings who live it
How the parasite that ‘gave up sex’ found more hosts – and why its victory won’t last
When is it time to jump? The boiling frog problem of AI use in physics education
Twitter data reveals partisan divide in understanding why pollen season's getting worse
AI is quick but risky for updating old software
Revolutionizing biosecurity: new multi-omics framework to transform invasive species management
From ancient herb to modern medicine: new review unveils the multi-targeted healing potential of Borago officinalis
[Press-News.org] Actos Bladder Cancer Lawsuits to See First Hearing, Kershaw, Cutter & Ratinoff ReportsAn initial court hearing date has been scheduled for the thousands of lawsuits against Takeda Pharmaceuticals over its best selling diabetes drug, Actos, which has been linked to an increased risk of bladder cancer.